Phase II trial of neoadjuvant S-1 and concurrent radiotherapy for borderline resectable pancreatic cancer (JASPAC05)

被引：0
|
作者：
Ohno, Izumi [1 ]
Takahashi, Shinichiro [2 ]
Kobayashi, Tatsushi [3 ]
Akimoto, Tetsuo [4 ]
Toyama, Hirochika [5 ]
Shimizu, Yasuhiro [6 ]
Morinaga, Soichiro [7 ]
Nakamori, Shoji [8 ]
Hishinuma, Shoichi [9 ]
Takakura, Norihisa [10 ]
Takayama, Wataru [11 ]
Hirano, Satoshi [12 ]
Otsubo, Takehito [13 ]
Ikeda, Masafumi [1 ]
Uesaka, Katsuhiko [14 ]
机构：
[1] Natl Canc Ctr East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, Japan
[2] Natl Canc Ctr Hosp East, Dept Hepatobiliary Pancreat Surg, Kashiwa, Chiba, Japan
[3] Natl Canc Ctr Hosp East, Dept Diagnost Radiol, Kashiwa, Chiba, Japan
[4] Natl Canc Ctr Hosp East, Div Radiat Oncol & Particle Therapy, Kashiwa, Chiba, Japan
[5] Kobe Univ, Grad Sch Med, Dept Hepatobiliary Pancreat Surg, Kobe, Hyogo, Japan
[6] Aichi Canc Ctr Hosp, Dept Surg Gastroenterol, Nagoya, Aichi, Japan
[7] Kanagawa Canc Ctr, Dept Surg Gastroenterol, Yokohama, Kanagawa, Japan
[8] Natl Hosp Org Osaka Natl Hosp, Dept Hepatobiliary Pancreat Surg, Osaka, Japan
[9] Tochigi Canc Ctr, Dept Hepatobiliary Pancreat Surg, Utsunomiya, Tochigi, Japan
[10] Fukuyama City Hosp, Dept Surg, Fukuyama, Hiroshima, Japan
[11] Chiba Canc Ctr, Dept Hepatobiliary Pancreat Surg, Chiba, Japan
[12] Hokkaido Univ, Fac Med, Dept Gastroenterol Surg 2, Sapporo, Hokkaido, Japan
[13] St Marianna Univ, Sch Med Hosp, Dept Gastroenterol Surg, Kawasaki, Kanagawa, Japan
[14] Shizuoka Canc Ctr, Dept Hepatobiliary Pancreat Surg, Nagaizumi, Shizuoka, Japan
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O3 - 11 -
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Neoadjuvant chemotherapy with gemcitabine and S-1 for resectable and borderline pancreatic ductal adenocarcinoma: A prospective, multi-institutional, phase II trial
    Mizuma, Masamichi
    Motoi, Fuyuhiko
    Ishida, Kazuyuki
    Fujishima, Fumiyoshi
    Ottomo, Shigeru
    Oikawa, Masaya
    Okada, Takaho
    Shimamura, Hiromune
    Takemura, Shinichi
    Ono, Fuminori
    Akada, Masanori
    Nakagawa, Kei
    Katayose, Yu
    Egawa, Shinichi
    Unno, Michiaki
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [22] A phase I trial of S-1 with concurrent radiotherapy for locally advanced pancreatic cancer
    M Ikeda
    T Okusaka
    Y Ito
    H Ueno
    C Morizane
    J Furuse
    H Ishii
    M Kawashima
    Y Kagami
    H Ikeda
    British Journal of Cancer, 2007, 96 : 1650 - 1655
  • [23] The effect of neoadjuvant chemotherapy with gemcitabine and S-1 for resectable pancreatic cancer (randomized phase II/III trial; Prep-02/JS']JSAP-05).
    Satoi, Sohei
    Unno, Michiaki
    Motoi, Fuyuhiko
    Matsuyama, Yutaka
    Matsumoto, Ippei
    Aosasa, Suefumi
    Shirakawa, Hirofumi
    Wada, Keita
    Fujii, Tsutomu
    Yoshitomi, Hideyuki
    Takahashi, Shinichiro
    Sho, Masayuki
    Ueno, Hideki
    Yamamoto, Tomohisa
    Kosuge, Tomoo
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [24] Neoadjuvant Chemoradiotherapy With S-1 in Patients With Borderline Resectable Pancreatic Cancer with Involvement of the Major Artery
    Suenaga, M.
    Fujii, T.
    Yamada, S.
    Okumura, N.
    Kobayashi, D.
    Tanaka, C.
    Nakayama, G.
    Sugimoto, H.
    Koike, M.
    Nomoto, S.
    Fujiwara, M.
    Takeda, S.
    Nakao, A.
    Kodera, Y.
    PANCREAS, 2012, 41 (08) : 1405 - 1405
  • [25] Outcomes of neoadjuvant gemcitabine plus S-1 and radiation therapy for borderline resectable pancreatic cancer
    Yabushita, Yasuhiro
    Matsuyama, Ryusei
    Miyake, Kentaro
    Homma, Yuki
    Kumamoto, Takafumi
    Misumi, Toshihiro
    Hata, Masaharu
    Yamanaka, Shoji
    Fujii, Satoshi
    Endo, Itaru
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2023, 30 (04) : 493 - 502
  • [26] Prospective phase II trial of neoadjuvant chemotherapy with gemcitabine and S-1 (GS) for borderline resectable (BR)/unresectable (UR) pancreatic cancer (CAP-003 study).
    Yoshitomi, Hideyuki
    Takano, Shigetsugu
    Kagawa, Shingo
    Furukawa, Katsunori
    Takayashiki, Tsukasa
    Kuboki, Satoshi
    Miyazaki, Masaru
    Ohtsuka, Masayuki
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [27] Optimizing neoadjuvant radiotherapy for resectable and borderline resectable pancreatic cancer using protons
    Nichols, Romaine Charles
    Rutenberg, Michael
    WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2019, 11 (07): : 303 - 307
  • [28] A phase II study of gemcitabine/nab-paclitaxel/S-1 combination neoadjuvant chemotherapy for patients with borderline resectable pancreatic cancer with arterial contact
    Kondo, Naru
    Uemura, Kenichiro
    Sudo, Takeshi
    Hashimoto, Yasushi
    Sumiyoshi, Tatsuaki
    Okada, Kenjiro
    Seo, Shingo
    Otsuka, Hiroyuki
    Murakami, Yoshiaki
    Takahashi, Shinya
    EUROPEAN JOURNAL OF CANCER, 2021, 159 : 215 - 223
  • [29] HOPS-R01 phase II trial evaluating neoadjuvant S-1 therapy for resectable pancreatic adenocarcinoma
    Toru Nakamura
    Tsuyoshi Hayashi
    Yasutoshi Kimura
    Hiroshi Kawakami
    Kuniyuki Takahashi
    Hirotoshi Ishiwatari
    Takuma Goto
    Masayo Motoya
    Keisuke Yamakita
    Yusuke Sakuhara
    Michihiro Ono
    Eiichi Tanaka
    Makoto Omi
    Katsuhiko Murakawa
    Tomoya Iida
    Tamaki Sakurai
    Shin Haba
    Takehiro Abiko
    Yoichi M. Ito
    Hiroyuki Maguchi
    Satoshi Hirano
    Scientific Reports, 12 (1)
  • [30] A Phase II Trial of Neoadjuvant S-1 Therapy in Patients With Resectable Pancreatic Adenocarcinoma: HOPS-R01
    Nakamura, T.
    Kawakami, H.
    Takahashi, K.
    Kimura, Y.
    Hayashi, T.
    Ishiwatari, H.
    Motoya, M.
    Goto, T.
    Yamakita, K.
    Sakuhara, Y.
    Maguchi, H.
    Hirano, S.
    PANCREAS, 2019, 48 (10) : 1496 - 1496
12345